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Potassium deficiency in chronic renal failure. That total body
potassium depletion may occur in the presence of a normal or
high serum K concentration in patients with end-stage renal
disease is controversial. Since muscle K stores are the best
single index of body potassium stores, we measured sketetal
muscle water, Na , K+ and Cl - content in volunteers, in
patients with stable chronic renal failure (CRF) and in patients
maintained on chronic hemodialysis (CHD). Skeletal muscle
resting membrane potential (Em), measured in the anterior tibial
compartment to facilitate calculation of intracellular electrolyte
concentrations, was immediately followed by the procurement
of muscle samples, obtained by percutaneous needle biopsy
of the thigh. Chronic renal failure was associated with a
high intracellular Na concentration; (20.4 mEq/liter of intra-
cellular water (ICW); normal= 11.4, P<0.00l), a low intra-
cellular K concentration, (126 mEq/liter of ICW; normal=
155, P<0.00l) and a low Em(76.7mv; normal=—86.7mv,
P< 0.001). After chronic hemodialysis for six weeks' duration,
the intracellular electrolyte concentration returned to normal
but the Em remained low (—75 my). We conclude that K
deficiency is common in advanced CRF despite a normal serum
K concentration, and is corrected by hemodialysis.
Déplétion en potassium dans I'insuffisance rénale chronique La
survenue éventuelle d'une déplétion en potassium en presence
d'une concentration normale ou Clevée de potassium plasmati-
que chez des malades atteints d'insuffisance rénale terminale est
discutée. Du fait que Ic potassium musculaire est Ic meilleur
index du potassium total nous avons mesurC les contenus du
muscle squelettique en eau, Na, K et C1 chez des volon-
taires, des malades atteints d'insuffisance rénale chronique stable
(CRF) et des malades soumis a I'hemodialyse iterative. Le poten-
tiel de repos membranaire du muscle squelettique (Em) a été
mesurC dans Ia loge tibiale antCrieure afin de faciliter le calcul
des concentrations intracellulaires. Les Cchantillons musculaires
ont Cté prelevés immCdiatement après, pour biopsie percutanée a
l'aiguille de Ia cuisse. A l'insuffisance rénale chronique Ctaient
associCs une concentration intracellulaire élevée en Na + (20,4
mEq par litre d'eau intracellulaire (ICW): valeur normale:
11,4; P <0,001); une concentration intracellulaire de K basse
(126 mEq par litre d'ICW, valeur normale: 155; P <0,001) et
une baisse de Em (—76,7 my, valeur normale: —86,7 my;
P< 0,001). AprCs six semaines d'hemodialyse chronique les con-
centrations sont revenues a Ia normale mais Em est restC bas
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(—75 my). Nous concluons que Ia déplétion en K est fré-
quente dans l'insuffisance rCnale chronique avancée, en dCpit
d'une kaliémie normale, et qu'elle est corrigee par l'hemodialyse.
Potassium (K) deficiency is a potentially serious
disorder which may be responsible for a multitude of
important functional, metabolic and structural ab-
normalities. Chronic renal failure, often accompanied
by the clinical syndrome of uremia, is encompassed by
many factors which could lead to K + deficiency. Thus,
a fastidious or improper diet, vomiting, diarrhea,
chronic acidosis and therapeutic use of drugs which
facilitate loss of K could all play a role. Most
recently, evidence has been offered suggesting that
aldosterone, which is apparently produced excessively
in some patients with renal failure [1], may promote
loss of K into the colon [2].
It might be argued that since patients with uremia
generally demonstrate a normal or increased serum
potassium concentration, deficits of potassium would
be highly unlikely. Nevertheless, it has been shown,
primarily by isotope dilution studies, that deficits of
total body K + in excess of catabolic tissue losses may
prevail in patients with diabetic ketoacidosis [3],
chronic respiratory acidosis [4], chronic congestive
heart failure [5, 8], essential hypernatremia [6] in
patients receiving diuretics [7] and in cirrhosis of the
liver [8] despite the absence of hypokalemia.
Assessment of body potassium stores in patients
with chronic renal insufficiency has yielded conflicting
data. Although the majority of studies have indicated
that potassium deficiency exists [9—14], this view has
been challenged [15—17]. The controversy may be due
to I) selection of patients with different dietary man-
agement and varying degrees of chronic renal failure
(CRF), 2) the well recognized difficulties with short
half-life and equilibration time of potassium isotopes
and 3) unavailability of paired muscle biopsy data
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evaluating the potassium stores of CRF subjects be-
fore and after hemodialysis.
The purpose of our study was to reexamine the issue
of potassium deficiency in patients with moderate to
severe chronic renal failure. Potassium content deter-
mined from analysis of skeletal muscle obtained by per-
cutaneous needle biopsy was found to be low. That
correction of muscle potassium deficits occurred after
six or more weeks of hemodialysis therapy provides
strong evidence that potassium deficiency may exist
in patients with CRF despite normokalemia.
Methods
Patient selection. Clinical data pertaining to the
nine male patients with CRF are outlined in Table 1
and biopsy results are recorded in Tables 2 and 3.
Each patient had consumed a diet containing 40 g of
protein and 2 g of sodium for a minimum of four weeks
prior to admission. Blood urea nitrogen and serum
creatinine concentrations had remained stable from
three weeks to six months. Five of the nine CRF
individuals (patients 1, 3, 6, 7 and 8) were studied on a
second occasion after a minimum duration of hemo-
dialysis therapy from 6 to 12 weeks. Each received
between 12 and 18 hours of hemodialysis per week on a
coil dialyzer with a K concentration of 2.0 mEq/liter
in the dialysis bath. Four additional male patients on
chronic hemodialysis (patients 10 through 13) receiving
identical dialysis therapy were also studied. Results
were compared to a control group consisting of eight
normal male subjects whose average age was 30 years.
Muscle biopsy. Duplicate samples of skeletal muscle
(10 to 20 mg wet weight) were obtained from all
patients and control subjects by percutaneous needle
biopsy (Baylor biopsy needle, Sol Popper and Sons,
New York) of the right lateral thigh under local
anesthesia according to the method described by
Nichols, Hazelwood and Barnes [18]. The precise
time when muscle samples were obtained was noted
and serial weight determinations were made using an
electrobalance (Cahn) at precise intervals over a total
time of less than five minutes. The initial weight of the
specimen was estimated by extrapolation of serial
weights on a graph through the zero-time intercept.
Samples were transferred to chemically clean glass
(Pyrex) tubes and dried overnight in a vacuum oven
at 73°C. After drying, muscle weight was recorded,
muscle fat was extracted with petroleum ether for at
least six hours and samples were again dried to a
constant weight to obtain the fat-free dry solids
(FFDS). Samples were then placed in sterile plastic
tissue culture tubes (Falcon Plastics, Oxnard, Cali-
fornia) containing 5 ml of 10% acetic acid solution
and 0.015 M lithium nitrate. The lithium nitrate thus
added provided an appropriate internal flame photo-
metric standard. The plastic tubes containing the
muscle samples were placed in a metabolic shaker
(Dubnoff) for 24 hours at 37°C and thereafter the
supernatant was analyzed for sodium and potassium
concentration using a flame photometer (IL Model 143)
The flame photometer was adjusted to zero with acetic
acid-lithium solution and standardized with a solution
containing acetic acid (10%), lithium nitrate (15 mEq/
liter), NaCl (0.1 mEq/liter), and KC1 (0.4 mEq/liter),
with Na and K readings set at 20 and 80, respectively.
To obtain the true concentration, standard and sample
Table 1. Clinical parameters of CRF and CHD patientss
Patient Age,
years
Venous
pH
BUN,
mg/100 ml
Serum
creatinine,
mg/100 ml
Diagnosis Serum
albumin,
g/100 ml
Edema
1. 44 7.40 96 12.1 CGNb 3.7 None
2. 31 7.39 69 8.7 CGN and hypo-
plastic right
kidney
4.8 None
Moderate3. 48 7.39 100 16.8 CGN 3.7
4. 59 7.47 165 18.0 Nephrosclerosis 3.4
4.1
Mild
Moderate5. 49 7.32 125 13.5 CON
6. 56 7.35 132 28.4 Nephrosclerosis 2.6 MildMild7. 54 — 105 23.2 Nephrosclerosis 3.5
8. 60 7.50 151 15.7 Diabetes and
nephrosclerosis
3.8 None
None9. 45 7.43 37 4.0 CGN
10. 54 — 120 16.4 Diabetes 4.5 None
11. 40 — 81 16.8 Nephrosclerosis 3.0 NoneNone12. 57 — 63 8.7 CON
13. 46 — 50 11.2 Nephrosclerosis 3.2 None
a CRF=chronic renal failure; CHD=chronic hemodialysis.
b CGN=chronic glomerulonephritis.
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readings were divided by 200. The standard curve for
sodium concentration was linear between 0.025 and
0.150 mEq/liter; for potassium, between 0.1 and 0.6
mEq/liter.
Two milliliters of supernatant were used for duplicate
chloride analysis by the method of Nichols et al using
a 680 megohm external resistor on the chioridometer
(Cotlove) [18].
In preliminary studies, a consistent problem of an
abnormally high Na + content was encountered, even
in normal samples. In Table 4, data are presented for
Na and K content of unpaired specimens in 12
Table 2. Muscle composition and Em in normal, chronic renal failure (CRF) and chronic hemodialysis (CHD) subjectsa
Subject H20,
%
Na Cl; K TW ECW ICW [Nal1 [C1]1 [K]1 [KJECW
lNalECW
Goldmanb
Em(—mv)
Measured
Em(mv)
Normals
14.
15.
16.
17.
18.
19.
20.
21.
77.8
78.4
75.3
73.1
75.9
75.7
75.6
76.0
12.2
9.4
12.0
10.6
9.7
11.4
10.0
8.7
8.4
5.6
8.2
6.1
5.5
9.4
6.4
6.4
43.0
43.6
46.6
40.4
43.1
39.1
40.9
43.5
360
382
332
279
319
318
310
316
64
34
60
44
39
72
44
45
296
348
272
235
280
246
266
271
10.1
12.4
12.5
18.7
14.3
2.2
13.3
7.5
3.8
4.6
5.6
4.4
4.0
4.4
4.5
4.3
145
125
171
172
154
159
154
160
4.4/145
4.6/149
4.0/144
4.4/140
4.4/147
4.7/151
4.3/147
4.2/148
85.8
80.7
92.1
90.6
87.2
86.6
87.7
89.2
90.9
86.0
80.0
87.1
87.7
87.2
87.0
88.0
Mean
SD
76.0
1.6
10.5
1.3
7.0
1.5
42.5
2.3
327
32
50
13
277
34
11.4
4,9
4.4
0.5
155
15
4.4/146
0.2/3.4
87.4
3.5
86.7
3.1
CRF
6.
3.
1.
8.
7.
4.
5.
9.
2.
80.3
79.5
72.0
73.6
78.1
77.7
76.0
75.4
74.4
19.7
16.5
15.8
8.4
14.5
12.5
13.4
11.0
9.0
10.1
8.4
5.4
2.2
9.5
8.8
10.3
6.3
5,4
39.5
36.9
39.6
37.8
38.9
37.8
37.2
38.1
37.1
456
402
307
306
361
365
344
338
319
63
35
21
9
78
75
74
45
35
393
367
286
297
283
290
270
293
284
26.9
31.2
44.8
24.0
14.0
5.5
9.3
15.5
12.8
7.8
12.2
10.8
4.2
5.3
4.8
4.0
4.8
6.3
101
101
138
127
137
130
138
130
132
7.5/139
5.4/139
5.3/143
3.7/142
4.9/135
3.3/144
5.5/146
3.8/138
3.4/147
65.0
72.2
80.7
85.8
82.4
88.6
79.7
86.3
88.1
71.0
59.0
65.0
85.2
78.9
81.0
92.0
83.0
75.0
Mean
SD
76.3
2.8
13.4
3.7
7.4
2.7
38.1
1.0
355
49
48
25
307
43
20.4
12.4
6.7
3.0
126
15
4.8/141
1.4/4.0
81.0
7.9
76.7
10.3
CHD
6.
3Cl.
8.c
7C
10.
fl.
12.
13.
78.8
77.5
77.8
76.2
77.7
78.7
79.4
76.9
77,9
9.9
10.9
12.4
8.8
12.8
11.6
14.6
14.2
16.!
6.8
7.0
11.7
6.9
10.4
7.4
8.6
9.4
12.6
51.1
46.5
47.1
42.8
46.6
45.4
47.2
40.0
42.6
381
353
366
324
351
382
390
412
388
35
—
100
48
92
55
59
69
112
346
—
266
276
259
327
331
343
276
14.4
—
0.0
7.1
1.2
12.5
18.1
13.4
1.8
9.0
—
5.0
7.3
5.4
5.2
6.4
5.6
6.8
148
—
177
155
180
139
142
117
154
5.0/140
—
5.2/137
4.8/136
7.6/136
5.0/137
4.4/145
3.9/139
4.6/139
83.9
—
87.9
86.2
79.9
82.3
85.2
82.7
86.7
66.0
—
81.0
70.0
78.0
80.0
76.0
78.7
70.6
Mean
SD
77,9
1.0
12.4
2.3
9.0
2.2
45.5
3.3
372
26
71
27
303
37
8.6
7.0
6.3
1.3
152
20
5.1/139
1.1/3.0
84.4
2.6
75.0
5.5
Definition of terms: Nat, Cl;, K =mEq/100 g of fat-free dryweight (FFDW); TW, ECW and ICW=total, extracellular and intracellular
water/100 g of FFDW; tNa]1, [Cl-]1, [Ki1 mEq/liter of ICW.(KJ1b Goldman Em = —61.5 log1 M +1I JO ' L a JO
Patients studied before and after hemodialysis.
Table 3. Muscle composition and Em before and after CHD in five, patients
H20, Na Cl; K TW ECW ICW [Na]j [Cl-)1 [Ki1 [K] ECW Goldman Measured C1[NaJECW E0.(—mv) Em('mv) ECW
Before (N= 5)
CHD (
SD
76.5 15.0
3.7 4.1
7.1
3.3
38.5
1.2
344
46
36
30
308
40
28.5
13.0
8.1
4.0
126
17
4.8/140
0.8/3.6
80.3
5.8
72.0
12.1
106
4.7
After (N=5)
CHD X
SD
77.6 11.0
0.9 1.7
8.6
2.3
46.8
2.9
356
24
69
32
287
40
5.7
6.6
6.7
1.8
165
16
5.6/137
1.3/1.9
84.5
3.5
73.8
6.9
103
2.8
P value" — 0.025 — 0.001 — 0.05 0.001 0.01 — 0.001 — — — 0.01
O See Table 2 for abbreviations.
b p values were obtained by paired analysis of values obtained before and after CHD.
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Table 4. Measurement of dog skeletal muscle electrolyte content
in glass versus plastic tubes
Muscle weight,
mg of FFDSa
Sodium,
mEq/100 g
of FFDS
Potassium,
mEq/100 g
of FFDS
Glass tubes 2.697
3.612
3.885
4.650
7.275
7.680
23.0
19.4
30.4
17.6
11.3
13.3
47.5
47.6
45.8
49.9
45.4
46.9
Mean 4.967
2.05
19.2
6.9
47.2
1,6
Plastic tubes 2.768
2.877
4.235
4.248
6.164
6.953
11.3
9.6
8.6
10.0
9.5
8.8
45.2
46.0
42.5
48.2
45.8
43.5
Mean 4.541
1.71
9.6
1.0
45.2
2,0
a FFDS=fat.free dry solids.
normal dogs. These were prepared in an identical
manner except that after drying electrolytes were
extracted from six specimens incubated in glass tubes
whereas the remaining samples were processed in
plastic tissue culture tubes. These data indicate that a
mean 100% error was introduced, presumably by
leaching Na from glass. This occurred regardless of
the type of glass used or the method of cleaning.
Incubation in glassware had no significant effect on
K + measurements.
Membrane potential. The resting skeletal muscle
membrane potential (Em) was measured in all patients
and control subjects. Measurements of Em were ob-
tained by puncturing muscle cells of the anterior tibial
compartment with Ling-type electrodes, using the
technique previously reported from this laboratory
[19]. This value was used to partition extracellular
(ECW) and intracellular (ICW) water compartments
according to the passive distribution of chloride by
equations previously published [19]. Electrolyte con-
centrations in ECW were calculated using Donnan
factors of 0.96 for cations and 1.04 for anions.
Results
Muscle compositions. Percutaneous needle biopsy of
skeletal muscle is easily performed and well accepted by
patients. Complications, such as infection or hematoma
of the biopsy site, did not occur. The method of
analyzing small muscle samples reported herein has
been previously examined in the dog (unpublished
observations) in which results obtained by analysis of
samples weighing 0.941 to 1.645 g compared favorably
with results obtained on samples weighing 10 to 20 mg.
Mean muscle electrolyte content of normal subjects
was as follows: Nat, 10.5 mEq; Cl, 7.0 mEq; and
K, 42.5 mEq/l00 g of FFDS (Table 2). These values
compared favorably with most reported values derived
from analysis of larger samples obtained via open
excision biopsy. Our values for muscle Na content
(Table 2) agree closely with those obtained by Berg-
strom using needle biopsy, analyzed by neutron acti-
vation [17]. In contrast, considerably higher values
for muscle Na content were reported by Nichols et al
[20] using the needle biopsy technique; we feel that
the higher values which they obtained are probably
due to sodium contamination. The use of plastic tissue
culture tubes (see Methods) has eliminated this pro-
blem, making possible serial and accurate analysis of
small muscle samples during disease states with no
associated complications.
In normal subjects, muscle K content and intra-
cellular K concentration were 42.5 2.3 mEq/l00 g
of FFDS, (SD) and 155 15 mEq/liter of intracellular
water, respectively (Table 2). The slight depressed
intracellular K concentrations in one normal subject
(15) was probably due to an error in determining
muscle water content (Table 2). In contrast, in patients
with CRF the respective average muscle K + content
and K concentration in intracellular water were
38.1 1.0 (SD), (P<0.OOl), and 126±15 (SD), (P<
0.005), at a time when the mean serum K concentration
was normal (4.8 mEq/liter). Only two patients demon-
strated slight hypokalemia (subjects 2 and 4, Table 2).
In normal subjects, average muscle Na content
and Na concentration in intracellular water were
10.5 1.3 mEq/lOOg of FFDS (SD) and 11.4±4.9 mEq/
liter. By contrast, in patients with CRF, average
muscle Na content and Na concentration in
intracellular water were 13.4 3.7 (SD) mEq/l00 g of
FFDS (P <0.025) and 20.4 12.4 mEq/liter(P <0.005),
respectively. Sodium and C1 concentration in extra-
cellular water in patients with CRF were significantly
lower than normal (P<0.025).
The abnormally low K content in skeletal muscle
observed in patients with CRF was corrected by
chronic hemodialysis. Mean values for muscle K
content and concentration in nine chronic hemo-
dialysis (CHD) patients were 45.5±3.3 and 152±20
(SD), respectively (Table 2). In contrast, despite the
complete reversal of the subnormal muscle K + content,
muscle Na + content remained significantly elevated
compared to control subjects (P <0.05) although
intracellular Na + concentration in muscle returned to
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the normal range. The reason for this apparent dis-
crepancy is evident on further examination of the data
in Table 2. Muscle water content in CRF patients is
not different from that in controls. In contrast, muscle
water is paradoxically elevated in CHD patients
(P< 0.001) and ECW accounts for most of the increase.
The increase in ECW is considered paradoxical in that
all of these patients had attained their dry weight after
dialysis (as determined by induction of hypotension)
before the time of biopsy, and all biopsies were done
on the day following their last dialysis. The correction
of muscle K + with similar responses of muscle water
and Na' is confirmed in the five patients studied
before and after hemodialysis (Table 3).
Muscle membrane potential. The resting skeletal
muscle membrane potential (Em) measured in normal
controls and patients with CRF are given for each
individual in Table 2. When Em was measured in each
normal subject and patient, the usual stairstep in-
crease in Em that has been previously described [19] was
found as the electrode penetrated into deeper muscle
fibers. Thus, a plateau was attained which is defined as
that point where successive impalement of muscle
fibers gave a constant value. Upon reaching the
pleateau, a minimum of ten muscle potentials were
recorded in each patient and averaged.
Predicted values for Em (Table 2) were calculated
from values for electrolyte content of the muscle and
the extracellular fluid, using the equation derived by
Goldman [21]:
E ——xlF [K]0 + 0.01 [Na]0
where RT/F have the usual connotation and where the
value for RT 2.203/F at 37°C has a value of 61.5. The
Em, therefore, is equal to the log of the ratio (K)1/
(K)0+0.0l Na0 multiplied by —61.5.
Normal subjects (Table 2) had a mean measured
Em of —86.7±3.1 mY. This compared favorably with
the mean predicted Em of —87.4 3.5 my. Individual
subjects for the most part had measured Em'5 within
5 my or less of their predicted Em.
The patients with CRF (Table 2) by and large had
lower measured Em than the normal subjects. It is of
interest that the mean predicted Em of this group,
—81.0± 7.9, although only 6mv different than the
predicted Em for the normal subjects, was significantly
different from that value (P <0.025). The mean meas-
ured Em for this group, however, was considerably
below normal, —76.7 10.3, a value again significantly
different from that of the normal subject (P<0.0l).
All of the CRF patients had reduced intracellular
potassium concentration, but several of the patients
(subjects 5, 8 and 9) had normal or near normal
measured Em. One of these patients (subjectS) had a nor-
mal Em despite the low intracellular K concentration.
It is of interest that he also had a normal intracellular
Na concentration (9.3 mEq/liter). On the other hand,
an additional patient (subject 4) also had a normal
intracellular Na concentration (5.5 mEq/Iiter) but
despite this had a measured Em (—81.0 my) con-
siderably below his predicted value of —88.6 my.
Of major importance are the data on patients who
were undergoing chronic hemodialysis (CHD, Table
2). It can be seen that despite near correction of the
intracellular potassium and sodium concentrations,
none of the patients demonstrated a normal measured
Em. In five of the patients data are available during
the period of conservative therapy for CRF and fol-
lowing CHD. It is of interest to note that although
there was return of intracellular electrolytes to normal,
in one case, there was no change in the measured Em
(patient 7). Likewise, in one of the patients (8) a
known diabetic, the measured membrane potential
actually fell after the institution of hemodialysis from
a previous value of —85 my to a value of —70 my. In
one of the patients (6), the measured Em rose follow-
ing hemodialysis. However, the change was only
5 my and was insufficient to bring measured Em to
within the normal range. Another of these patients (1)
had a significant rise of Em but had no intracellular
Na present by calculation. This probably resulted
from an error in the measurement of Em or muscle
chloride content.
To summarize the Em data in these patients, it
appears that during the period of CRF there is de-
creased intracellular K concentration. The predicted
Em, in general, is below that which would be con-
sidered a normal Em for skeletal muscle. However, the
measured Em is well below that predicted. In the time
period studied, although muscle electrolytes tended to
return towards normal, the measured Em remained
very similar to that found during the period of CRF.
Discussion
Possible harmful consequences of potassium defi-
ciency on the functional and structural integrity of
many organ systems is well known. In patients with
uremia, at least one abnormality which may be related
to potassium deficiency is their ubiquitous impaired
ability to utilize an exogenous glucose load. Spergel
et al have shown that glucose-intolerant uremic pa-
tients given potassium chloride supplementation show
a rise in exchangeable potassium and simultaneous
correction of their defect in glucose utilization [22].
Hemodialysis resulted in improved glucose tolerance
in each of our CRF patients (unpublished observa-
tions), thus suggesting the possibility that improved
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glucose utilization was related to correction of muscle
potassium deficits. The precise role of K' deficiency
in any of the other metabolic or functional disorders of
uremia has not been conclusively studied.
In healthy subjects, body potassium stores can be
reasonably assessed in terms of lean body mass. In
turn, lean body mass may be satisfactorily predicted in
healthy subjects from measurement of body specific
gravity, total body water or red blood cell mass [23].
However, comparably accurate methods do not exist
which would permit estimation of lean body mass in
patients with chronic debilitating disease. Utiliza-
tion of specific gravity to estimate lean body mass in
patients with uremia would appear to be unreliable
since this method is based upon a regression equation
determined on data from normal subjects. Patients
with uremia are commonly overhydrated and, con-
sequently, this could lead to an overestimation of lean
body mass. In many normal mammalian species, the
values for total body water divided by the factor 0.732
is a highly reproducible means to estimate lean body
mass [23] but not in those with chronic disease assoc-
iated with overhydration. Finally, chronic disease is
virtually always associated with anemia, thus nullify-
ing the red blood cell mass as an index for assessing
lean body mass.
For practical purposes, there are two methods by
which total body potassium can be assessed in patients
with renal failure. The first is by administration of a
potassium isotope and measuring the specific activity
of blood or urine at the time of equilibration. Previous
studies which reported a reduction of exchangeable
potassium in CRF [12—14] made the assumption that
24 hours was sufficient for complete equilibration of
the isotope (42K) with body potassium stores. Using
this same assumption, we measured exchangeable
42K by determining the specific activity of urine 24
hours after an orally administered dose of 150 to 200
iCi. Mean exchangeable 42K in the CRF subjects
reported herein was 2834 749 mEq SD compared to a
control mean of 3400 298 mEq SD (P <0.05). The
validity of these data, as well as the exchangeable 42K
studies cited above, can be seriously questioned in that
Boddy et al [16] used 43K (t of 22 hours) and sug-
gested that even 48 hours may be an insufficient time
for equilibration in CRF subjects. Thus, the variable
clinical states of hydration and isotope equilibration
time in patients with CRF probably result in inaccurate
estimates of total body potassium stores.
The second and, in our view, most valuable index of
body potassium stores is its concentration in skeletal
muscle. Thus, the demonstration that potassium con-
tent in skeletal muscle is initially subnormal and sub-
sequently rises concomitantly, either with improve-
ment of the disease process or after supplementation
with potassium salts, would constitute strong evidence
that a true deficit existed initially.
We have herein presented conclusive evidence that
skeletal muscle potassium content was subnormal in
uremic patients and rose in each after clinical improve-
ments effected by chronic dialysis therapy. It is to be
emphasized that expression of potassium content of
skeletal muscle in terms of fat-free dry solids excludes
those factors which could spuriously lower potassium
content in wet muscle such as fat or water. Thus, our
studies show that potassium content rose from a mean
predialysis value of 38.5 1.2 (SD) to 46.8 2.9 mEq/
100 g of FFDS (P<0.001) after chronic dialysis. This
is of particular interest since Patrick et al [14] have
demonstrated low leukocyte potassium in CRF sub-
jects which returns toward normal values with chronic
hemodialysis. Potassium deficiency in CRF has been
previously demonstrated from analysis of skeletal
muscle biopsies [9, 10] but the difference in muscle
potassium content between normal control subjects
and patients with chronic renal failure shown in our
studies agree most closely with those of Villamil et al
[11], who found muscle potassium content to be
40.0± 1.9 and 35.0±4.5 mEq/100 g of FFDS, res-
pectively. In contrast, a few studies have reported
normal values for skeletal muscle potassium content
in chronic renal failure [14, 15]. In one study [14] only
six of 33 patients showed a muscle potassium content
below 40 mEq/lOO g of FFDS. These results are diffi-
cult to interpret in that the severity of renal insuffi-
ciency was not stated. In the report of Graham,
Lawson and Linton [15], seven of 22 patients with
CRF had a muscle potassium content less than 40
mEq/I00 g of FFDS with no apparent correlation of
muscle potassium content with serum creatinine.
Nevertheless, the mean serum creatinine concentra-
tion of our CRF patients (15.6 mg/lOO ml) is signifi-
cantly higher than those of Graham et al (8.0 mgI
100 ml). More importantly, our studies in five patients
showed by direct measurement a significant increase in
skeletal muscle potassium content after therapy with
chronic hemodialysis.
Low skeletal muscle resting membrane potential
(Em) resulting from serious clinical illness and accom-
panied by a significant increase in intracellular sodium
concentration has been recently described by Cunning-
ham et al [19]. In their studies, eight of 21 seriously ill
patients had renal failure (serum creatinine concen-
tration, 6.4 to 24 mg/lOO ml) with a mean measured
Em of —64.1 7.5 my. Similar results in chronic
renal failure patients were reported by Bolte, Riecke
and RohI [24]. The results reported herein, utilizing
the same recording techniques, confirm the observa-
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tion of a low Em in the presence of renal failure (—76
SD 10.3 my). Although it is apparent from the data
(Table 2) that a normal or nearly normal muscle Em
may rarely be found in CRF, perhaps even more
striking is the observation that muscle Em tends to
remain suppressed despite clinically adequate chronic
hemodialysis (Table 2). This is true despite the fact
that, in the patients examined, there appeared to be
for the most part a normalization of their intracellular
sodium and potassium concentration (Table 2).
Whether or not longer periods of hemodialysis would
have resulted in the return of the Em to a normal value
remains to be investigated. Moreover, the precise
mechanism underlying the abnormally low Em in CRF
has not been identified in this study. The observed low
Em'S could have been the result of a partial failure of the
membrane due to a disturbance in the membrane
sodium/potassium ATPase or a relative increase in the
membrane permeability to sodium. The possibility
that a combination of these mechanisms working in
concert was the primary cause of the lower Em'S can-
not be determined by the current observations. It is
intriguing to speculate that an undefined uremic toxin
works directly on the sodium-potassium ATPase
pump not only in skeletal muscle but in other cellular
membranes [25]. As a consequence, the toxin could
alter the electrogenicity of this pump by changing the
ratio of sodium to potassium per cycle of pump ac-
tivity.
In conclusion, we have presented evidence that
skeletal muscle potassium deficiency in CRF is
accompanied by a low skeletal muscle resting membrane
potential and is corrected by chronic hemodialysis.
The mechanism(s) underlying the maintenance of
potassium deficiency in CRF and its correction by
hemodialysis are unknown. The presence of a normal
serum potassium concentration in most patients prob-
ably did not result from acidosis since the venous
pH was usually normal (Table 1). Secondly, a more
positive potassium balance may have resulted from
protein intake having been liberalized from 40 g in
CRF to 60 g daily during hemodialysis, resulting in an
increased potassium intake orally. Thirdly, chronic
hemodialysis may have resulted in a partial correction
of abnormal electrolyte flux across muscle cell mem-
branes.
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